Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
E

Failure to Document Indications for Psychotropic and Sedative Medications

Clovis, New Mexico Survey Completed on 11-18-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that each resident's drug regimen was free from unnecessary drugs by not providing adequate indications of use for certain medications based on the residents' diagnoses. For three residents reviewed, physician orders included medications such as Ativan, Trazadone, Hydroxyzine, and Lorazepam prescribed for conditions like agitation, anxiety, and insomnia. However, record reviews revealed that the corresponding diagnoses for agitation and insomnia were not documented in the residents' electronic health records (EHRs). For example, one resident was prescribed Ativan for agitated behavior and Trazadone for insomnia, but neither agitation nor insomnia was listed as a diagnosis in the EHR. Another resident was prescribed Lorazepam for agitation/anxiety, but anxiety was not documented as a diagnosis. Similarly, a third resident was prescribed Trazadone for insomnia without insomnia being listed as a diagnosis in the EHR. During an interview, the Director of Nursing confirmed that these medications were being administered for the indicated uses as per the physician's orders, despite the lack of corresponding diagnoses in the residents' records. The absence of documented indications for these medications constitutes a failure to ensure that drug regimens are free from unnecessary drugs, as required by regulation.

An unhandled error has occurred. Reload 🗙